| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-11-22 |
4 |
AS |
$14.40 |
$3,269 |
D/D |
(227) |
454,015 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-11-21 |
4 |
AS |
$13.45 |
$11,042 |
D/D |
(821) |
454,242 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-08-22 |
4 |
AS |
$12.10 |
$2,747 |
D/D |
(227) |
455,063 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-08-19 |
4 |
AS |
$12.04 |
$9,897 |
D/D |
(822) |
455,290 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-05-20 |
4 |
AS |
$10.11 |
$2,295 |
D/D |
(227) |
456,112 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-05-19 |
4 |
AS |
$10.20 |
$8,395 |
D/D |
(823) |
456,339 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-02-23 |
4 |
S |
$10.56 |
$4,192 |
D/D |
(397) |
456,415 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-01-16 |
4 |
AS |
$12.00 |
$89,868 |
D/D |
(7,489) |
456,812 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-04-18 |
4 |
D |
$9.69 |
$60,136 |
D/D |
(6,206) |
457,162 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2008-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
457,812 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-13 |
4 |
S |
$15.00 |
$513,388 |
D/D |
(33,950) |
462,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
463,368 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-01-06 |
4 |
AS |
$12.00 |
$24,072 |
D/D |
(2,006) |
464,301 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-11-24 |
4 |
AS |
$10.53 |
$1,085 |
D/D |
(103) |
465,136 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-08-24 |
4 |
AS |
$9.82 |
$1,002 |
D/D |
(102) |
465,239 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-05-22 |
4 |
S |
$8.52 |
$852 |
D/D |
(100) |
465,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,025 |
465,440 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2008-12-17 |
4 |
AS |
$12.02 |
$126,270 |
D/D |
(10,505) |
466,307 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-03-12 |
4 |
OE |
$0.23 |
$7,392 |
D/D |
32,000 |
474,276 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-23 |
4 |
AS |
$15.09 |
$1,539 |
D/D |
(102) |
475,475 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-18 |
4 |
A |
$15.37 |
$160,617 |
D/D |
10,450 |
475,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2008-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,000 |
476,812 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2017-11-21 |
4 |
AS |
$13.15 |
$10,796 |
D/D |
(821) |
487,208 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2017-11-10 |
4 |
AS |
$13.12 |
$5,143 |
D/D |
(392) |
488,029 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-08-21 |
4 |
AS |
$15.20 |
$12,479 |
D/D |
(821) |
488,421 |
0 |
- |
|
173 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
